Cargando…
Obesity as a Possible Risk Factor for Progression from Monoclonal Gammopathy of Undetermined Significance Progression into Multiple Myeloma: Could Myeloma Be Prevented with Metformin Treatment?
Obesity is increasingly associated with the transformation of monoclonal gammopathy of undetermined significance (MGUS) into multiple myeloma (MM). Obesity, MGUS, and MM share common etiopathogenesis mechanisms including altered insulin axis and the action of inflammatory cytokines. Consistent with...
Autores principales: | da Cunha Júnior, Ademar Dantas, Zanette, Dalila Luciola, Pericole, Fernando Vieira, Olalla Saad, Sara Teresinha, Barreto Campello Carvalheira, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834834/ https://www.ncbi.nlm.nih.gov/pubmed/33531904 http://dx.doi.org/10.1155/2021/6615684 |
Ejemplares similares
-
Predictive Immune Markers for Disease Progression in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
por: Şahver İşgör, İrem, et al.
Publicado: (2022) -
Metformin and blood cancers
por: Cunha Júnior, Ademar Dantas, et al.
Publicado: (2018) -
Progression of Monoclonal Gammopathy with Undetermined Significance to Multiple Myeloma Diagnosed by Kidney Biopsy: A Case Report
por: Kim, Jin Hae, et al.
Publicado: (2015) -
Characterization of monoclonal gammopathy of undetermined significance progression to multiple myeloma through meta-analysis of GEO data
por: Aljabban, Jihad, et al.
Publicado: (2023) -
Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance()
por: Shimanovsky, Alexei, et al.
Publicado: (2016)